These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 15372720)

  • 21. Comparison of hospitalizations, emergency department visits, and costs in a historical cohort of Texas Medicaid patients with chronic obstructive pulmonary disease, by initial medication regimen.
    Rascati KL; Akazawa M; Johnsrud M; Stanford RH; Blanchette CM
    Clin Ther; 2007 Jun; 29(6):1203-13. PubMed ID: 17692734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resource utilization in asthma: combined fluticasone propionate/salmeterol compared with inhaled corticosteroids.
    Friedman HS; Yawn BP
    Curr Med Res Opin; 2007 Feb; 23(2):427-34. PubMed ID: 17288696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Levalbuterol in the treatment of patients with asthma and chronic obstructive lung disease.
    Dalonzo GE
    J Am Osteopath Assoc; 2004 Jul; 104(7):288-93. PubMed ID: 15293593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of levalbuterol with racemic albuterol in the treatment of acute severe asthma exacerbations in adults.
    Nowak R; Emerman C; Hanrahan JP; Parsey MV; Hanania NA; Claus R; Schaefer K; Baumgartner RA;
    Am J Emerg Med; 2006 May; 24(3):259-67. PubMed ID: 16635694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Levalbuterol and racemic albuterol: are there therapeutic differences?
    Ahrens R; Weinberger M
    J Allergy Clin Immunol; 2001 Nov; 108(5):681-4. PubMed ID: 11692088
    [No Abstract]   [Full Text] [Related]  

  • 26. Low-dose levalbuterol in children with asthma: safety and efficacy in comparison with placebo and racemic albuterol.
    Milgrom H; Skoner DP; Bensch G; Kim KT; Claus R; Baumgartner RA;
    J Allergy Clin Immunol; 2001 Dec; 108(6):938-45. PubMed ID: 11742271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral bronchodilators in the control of asthma.
    Rees PJ
    Natl Med J India; 1996; 9(4):153-4. PubMed ID: 8772328
    [No Abstract]   [Full Text] [Related]  

  • 28. The economic effect of the hydrofluoroalkane albuterol transition on children with asthma.
    Leo HL; Dombkowski KJ; Clark NM
    J Allergy Clin Immunol; 2008 Mar; 121(3):776-7. PubMed ID: 18328895
    [No Abstract]   [Full Text] [Related]  

  • 29. Bronchodilator resuscitation in the emergency department. Part 2 of 2: dosing strategies.
    Fink J; Dhand R
    Respir Care; 2000 May; 45(5):497-512. PubMed ID: 10813227
    [No Abstract]   [Full Text] [Related]  

  • 30. Albuterol in acute bronchiolitis--continued therapy despite poor response?
    Lugo RA; Salyer JW; Dean JM
    Pharmacotherapy; 1998; 18(1):198-202. PubMed ID: 9469694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Misconceptions regarding levalbuterol in the treatment of acute asthma exacerbations in children.
    Uspal NG; Agrawal D
    Am J Emerg Med; 2009 Jan; 27(1):117-119. PubMed ID: 19041546
    [No Abstract]   [Full Text] [Related]  

  • 32. Metabolic and electrocardiographic effects of albuterol in pediatric asthmatic patients treated in an emergency room setting.
    Del Río-Navarro B; Gazca-Aguilar A; Quibrera Matienzo JA; Rodríguez Galván Y; Sienra-Monge JJ
    Allergol Immunopathol (Madr); 1999; 27(1):18-23. PubMed ID: 10217668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of school-based health centers on children with asthma.
    Guo JJ; Jang R; Keller KN; McCracken AL; Pan W; Cluxton RJ
    J Adolesc Health; 2005 Oct; 37(4):266-74. PubMed ID: 16182136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continuous versus intermittent nebulization of salbutamol in acute severe asthma: a randomized, controlled trial.
    Besbes-Ouanes L; Nouira S; Elatrous S; Knani J; Boussarsar M; Abroug F
    Ann Emerg Med; 2000 Sep; 36(3):198-203. PubMed ID: 10969220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Point-counterpoint: A comparison of levalbuterol and racemic albuterol in the treatment of pediatric asthma.
    Abbott MB; Levin RH; Miller JA
    Pediatr Rev; 2004 Mar; 25(3):108-9. PubMed ID: 14993519
    [No Abstract]   [Full Text] [Related]  

  • 36. Prescriber and pharmacist responses to intervention letters for Connecticut Medicaid beneficiaries with asthma.
    Coleman CI; Reddy P; Laster-Bradley NM; Dorval S; Munagala B; White CM
    Am J Health Syst Pharm; 2003 Jun; 60(11):1142-4. PubMed ID: 12816025
    [No Abstract]   [Full Text] [Related]  

  • 37. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.
    Blanchette CM; Akazawa M; Dalal A; Simoni-Wastila L
    Am J Geriatr Pharmacother; 2008 Aug; 6(3):138-46. PubMed ID: 18775388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does adding ipratropium to salbutamol (albuterol) help children with asthma?
    Patel N; Phillips B
    Arch Dis Child; 2001 Nov; 85(5):432-3. PubMed ID: 12035817
    [No Abstract]   [Full Text] [Related]  

  • 39. A predictive score for unfavorable outcome of acute asthma in the emergency room.
    Boonsarngsuk V; Wangsuppasawad N; Kiatboonsri S; Kiatboonsri C; Choothakan S
    J Med Assoc Thai; 2007 Oct; 90(10):2003-9. PubMed ID: 18041416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retrospective claims study of fluticasone propionate/salmeterol fixed-dose combination use as initial asthma controller therapy in children despite guideline recommendations.
    Friedman HS; Eid NS; Crespi S; Wilcox TK; Reardon G
    Clin Ther; 2009 May; 31(5):1056-63. PubMed ID: 19539106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.